The role of insulin analogs in the achievement of compensation and improvement of quality of life in children and adolescents with type 1 diabetes mellitus
https://doi.org/10.14341/2072-0351-5504
Abstract
Despite substantial progress in the treatment of type 1 diabetes mellitus achieved by the end of the last century due to the advent of human insulins,intensive insulinotherapy, means of glycemia self-control, and active patient self-management education, compensation of the diseases in childrenand adolescents remains a challenging problem. This paper is focused on the use of insulin analogs in these patients and main difficulties encounteredby pediatricians in the correction of therapy.
References
1. Дедов И.И., Кураева Т.Л., Петеркова В.А. Сахарный диабет у детей и подростков. Руководство для врачей. - М.: ГЭОТАР-Медиа, 2007. - 247 с.
2. DCCT Research. Group. Epidemiology of severe hypoglycemia in the DCCT // Amer.J.Med. - 1991. - Vol.90. - P.450 459.
3. Дедов И.И., Петеркова В.А., Кураева Т.Л., Российский консенсус по терапии сахарного диабета у детей и подростков // Фарматека. - 2010. - 3. - С.7 14.
4. Алгоритмы специализированной медицинской помощи больным са- харным диабетом. / Под ред. И.И.Дедова и М.В.Шестаковой. - Изд. 4-е, доп. 4-й выпуск. - М., 2009. - 101 с.
5. ISPAD Clinical Practice Consensus Guidelines 2006-2007 // Pediatric Diabetes. - 2007. - V 8. - Р. 88-102.
6. ISPAD Clinical Practice Consensus Guidelines 2009 Compendium // Pediatric Diabetes. - 2009. - Vol.10, Suppl.12. - 210 p.
7. Петеркова В.А., Кураева Т.Л., Андрианова Е.А., Емельянов А.О. Ин- сулиновые аналоги в лечении сахарного диабета 1 типа у детей и подростков. Пособие для врачей / Под. Ред. И.И.Дедова. - М., 2010. - 48 с.
8. Dreyer M., Prager R., Robinson A., Busch K., Ellis G., Souhami E., Van Leendert R. Efficacy and safety of insulin glulisine in patients with type 1 diabetes // Horm Metab Res. - 2005. - Nov;37(11). - Р. 702-707.
9. Garg SK.New insulin analogues // Diabetes Technol Ther. - 2005. - Oct;7(5) . - Р. 813-817.
10. Goykhman S., Drincic A., Desmangles J.C., Rendell M. Insulin Glargine: a review 8 years after its introduction // Expert Opin Pharmacother. - 2009. - Mar;10(4). - P. 705 18/
11. Chase H.P., Arslanian S., White N.H., Tamborlane W.V. Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. // J Pediatr. - 2008. - Oct;153(4). - Р. 547-553.
12. White N.H., Chase H.P., Arslanian S., Tamborlane W.V. 4030 Study Group.Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes // Diabetes Care. - 2009. - Mar;32(3). - Р. 387 393.
13. Colino E., Lуpez-Capapй M., Golmayo L., Alvarez M.A., Alonso M., Barrio R. Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes // Diabetes Res Clin Pract. - 2005. - Oct;70(1) . - Р. 1-7.
14. Kuraeva T.L., Peterkova V.A., Andrianova E.A. et al. // Pediatric Diabetes. - 2004. - 5 (suppl 1). - Р. 36
15. Петеркова В.А.,Кураева Т.Л., Щербачева Л.Н. и др. Третья Всероссийская научно-практическая конференция // Тезисы докладов. - М. - 2005. - с.48.
16. Peterkova V.A., Kuraeva T.L., Emelyanov A.O., et al. Risk of nocturnal hypoglycaemia in children with type 1 diabetes mellitus treated with insulin glargine // Hormone Research. - 2006. - 9, (Suppl.2) . - P. 02-205.
17. Garcнa-Garcнa E., Galera R., Aguilera P., Cara G., Bonillo A. Long-term use of continuous subcutaneous insulin infusion compared with multiple daily injections of glargine in pediatric patients // J Pediatr Endocrinol Metab. - 2007. - Jan;20(1). - Р. 37 40.
18. Heise T., Nosek L., Rшnn B.B., Endahl L., Heinemann L., Kapitza C., Draeger E. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes // Diabetes. - 2004. - Jun;53(6). - Р. 1614 1620.
19. Robertson K.J., Schoenle E., Gucev Z., Mordhorst L., Gall M.A., Ludvigsson J. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes // Diabet Med. - 2007. - Jan;24(1). - Р. 27 34.
20. Danne T. et al. // Diabetes Care. - 2003. - 26(8). - Р. 2359-2364.
21. Hermansen K., Fontaine P., Kukolja K.K., Peterkova V., Leth G., Gall M.A. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes // Diabetologia. - 2004. - Apr;47(4). - Р. 622 629.
22. Barnett A.H. Treating to goal: challenges of current management // Eur. J. Endocrinol. - 2004. - Oct;151 Suppl 2. - Р. T3-7; discussion T29-30.
23. Rubin R.R., Peyrot M. Quality of life and diabetes // Diabetes Metab. Res. Rev. - 1999. - May-Jun;15(3). - Р. 205 218.
Review
For citations:
Kuraeva T.L. The role of insulin analogs in the achievement of compensation and improvement of quality of life in children and adolescents with type 1 diabetes mellitus. Diabetes mellitus. 2010;13(3):147-152. (In Russ.) https://doi.org/10.14341/2072-0351-5504
Views:
10444
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
